agency
suitable for USP L1
product line
Kromasil®
manufacturer/tradename
Kromasil® ET-5-C18-4.6X250
availability
available only in USA, Canada and Puerto Rico
extent of labeling
14% Carbon loading
technique(s)
HPLC: suitable
L × I.D.
250 mm × 4.6 mm
surface area
330 m2/g
particle size
5 μm
pore size
100 Å
pH range
1-12
application(s)
food and beverages
separation technique
reversed phase
Application
- Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.: This study developed and validated an HPLC-MS/MS method for determining clopidogrel in human plasma. The Kromasil® Eternity C18 HPLC column was employed to achieve the separation. This method was shown to be efficient, precise, and suitable for pharmacokinetic studies (Liu et al., 2016).
- Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.: The study focused on developing a stability-indicating assay method for atorvastatin and ezetimibe using UPLC. The Kromasil® Eternity C18 HPLC column was critical in achieving the required resolution and sensitivity, demonstrating its role in stability studies of pharmaceutical combinations (Goel et al., 2013).
Legal Information
Eternity is a trademark of EKA Chemicals AB
Kromasil is a registered trademark of EKA Chemicals AB
Still not finding the right product?
Explore all of our products under Kromasil® Eternity™ C18 高效液相色谱柱
法规信息
新产品
此项目有
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| K08670903 | 04061838551917 |